@article{c86bfe97e9514e30864a8a90edc7bd9c,
title = "AA amyloidosis associated with pulmonary squamous cell carcinoma treated with chemoradiation and immune checkpoint inhibitor therapy",
keywords = "Chemoradiotherapy/methods, Immune Checkpoint Inhibitors/therapeutic use, Humans, Amyloidosis/complications, Aged, 80 and over, Female, Neoplasms, Squamous Cell/complications, Nivolumab/therapeutic use, Lung Neoplasms/complications",
author = "Huan Mo and David Yau and Hamid Mirshahidi and Tricia Guadiz and Zuppan, {Craig W.} and Shino Magaki",
note = "Funding Information: We thank Mayo Clinic Laboratories for assistance with amyloid subtyping.",
year = "2020",
month = may,
day = "1",
doi = "10.1111/pin.12918",
language = "English",
volume = "70",
pages = "303--305",
journal = "Pathology International",
issn = "1320-5463",
number = "5",
}